Suppr超能文献

通过SUMO化和泛素化对Ets-1转录因子进行调控。

Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.

作者信息

Ji Z, Degerny C, Vintonenko N, Deheuninck J, Foveau B, Leroy C, Coll J, Tulasne D, Baert J-L, Fafeur V

机构信息

UMR 8161, Institut de Biologie de Lille, CNRS, Institut Pasteur de Lille, Université de Lille 1, Université de Lille 2, Lille Cedex, France.

出版信息

Oncogene. 2007 Jan 18;26(3):395-406. doi: 10.1038/sj.onc.1209789. Epub 2006 Jul 24.

Abstract

Sumoylation and ubiquitinylation reversibly regulate the activity of transcription factors through covalent attachment to lysine residues of target proteins. We examined whether the Ets-1 transcription factor is modified by sumoylation and/or ubiquitinylation. Among four potential SUMO motifs in Ets-1, we identified lysines 15 and 227 within the LK(15)YE and IK(227)QE motifs, as being the sumoylation acceptor sites. Using transfection of Ets-1 wildtype (WT) or its sumoylation deficient version (Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway, we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while a SUMO protease, SENP1, can desumoylate Ets-1. We also found that Ets-1 is modified by K48-linked polyubiquitinylation independently of the sumoylation acceptor sites and is degraded through the 26S proteasome pathway, while sumoylation of Ets-1 does not affect its stability. Finally, sumoylation of Ets-1 leads to reduced transactivation and we demonstrated that previously identified critical lysine residues in Synergistic Control motifs are the sumoylation acceptor sites of Ets-1. These data show that Ets-1 can be modified by sumoylation and/or ubiquitinylation, with sumoylation repressing transcriptional activity of Ets-1 and having no clear antagonistic action on the ubiquitin-proteasome degradation pathway.

摘要

SUMO化和泛素化通过与靶蛋白赖氨酸残基的共价连接可逆地调节转录因子的活性。我们研究了Ets-1转录因子是否被SUMO化和/或泛素化修饰。在Ets-1的四个潜在SUMO基序中,我们确定了LK(15)YE和IK(227)QE基序内的赖氨酸15和227为SUMO化接受位点。通过转染Ets-1野生型(WT)或其SUMO化缺陷型(Ets-1 K15R/K227R),以及SUMO途径的WT或突变蛋白,我们进一步证明E2 SUMO结合酶Ubc9和E3 SUMO连接酶PIASy可以增强Ets-1的SUMO化,而SUMO蛋白酶SENP1可以使Ets-1去SUMO化。我们还发现Ets-1被K48连接的多聚泛素化修饰,且独立于SUMO化接受位点,并通过26S蛋白酶体途径降解,而Ets-1的SUMO化不影响其稳定性。最后,Ets-1的SUMO化导致转录激活减少,并且我们证明先前在协同控制基序中鉴定的关键赖氨酸残基是Ets-1的SUMO化接受位点。这些数据表明Ets-1可以被SUMO化和/或泛素化修饰,SUMO化抑制Ets-1的转录活性,并且对泛素-蛋白酶体降解途径没有明显的拮抗作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验